These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15454229)

  • 1. Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors.
    Li Q; Wang GT; Li T; Gwaltney SL; Woods KW; Claiborne A; Wang X; Gu W; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5371-6. PubMed ID: 15454229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitors.
    Li Q; Claiborne A; Li T; Hasvold L; Stoll VS; Muchmore S; Jakob CG; Gu W; Cohen J; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5367-70. PubMed ID: 15454228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor.
    Lin NH; Wang L; Wang X; Wang GT; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5057-62. PubMed ID: 15380198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activity.
    Li Q; Li T; Woods KW; Gu WZ; Cohen J; Stoll VS; Galicia T; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2918-22. PubMed ID: 15911281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.
    Bell IM; Gallicchio SN; Abrams M; Beshore DC; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hartman GD; Heimbrook DC; Homnick CF; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Miller PA; Omer CA; Rodrigues AD; Walsh ES; Williams TM
    J Med Chem; 2001 Aug; 44(18):2933-49. PubMed ID: 11520202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 4-[3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl]-1-yl-benzonitrile as novel farnesyltransferase inhibitor.
    Lin NH; Wang L; Cohen J; Gu WZ; Frost D; Zhang H; Rosenberg S; Sham H
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1293-6. PubMed ID: 12657267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 4-[(3-methyl-3H-imidazol-4-yl)-(2-phenylethynyl-benzyloxy)-methyl]-benzonitrile as novel farnesyltransferase inhibitor.
    Lin NH; Wang L; Cohen J; Gu WZ; Frost D; Zhang H; Rosenberg S; Sham H
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3821-5. PubMed ID: 14552788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
    Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase.
    Curtin ML; Florjancic AS; Cohen J; Gu WZ; Frost DJ; Muchmore SW; Sham HL
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1367-71. PubMed ID: 12657284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.
    Wang L; Wang GT; Wang X; Tong Y; Sullivan G; Park D; Leonard NM; Li Q; Cohen J; Gu WZ; Zhang H; Bauch JL; Jakob CG; Hutchins CW; Stoll VS; Marsh K; Rosenberg SH; Sham HL; Lin NH
    J Med Chem; 2004 Jan; 47(3):612-26. PubMed ID: 14736242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability.
    Tong Y; Lin NH; Wang L; Hasvold L; Wang W; Leonard N; Li T; Li Q; Cohen J; Gu WZ; Zhang H; Stoll V; Bauch J; Marsh K; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2003 May; 13(9):1571-4. PubMed ID: 12699757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase.
    Anthony NJ; Gomez RP; Schaber MD; Mosser SD; Hamilton KA; O'Neil TJ; Koblan KS; Graham SL; Hartman GD; Shah D; Rands E; Kohl NE; Gibbs JB; Oliff AI
    J Med Chem; 1999 Aug; 42(17):3356-68. PubMed ID: 10464022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
    Hunt JT; Ding CZ; Batorsky R; Bednarz M; Bhide R; Cho Y; Chong S; Chao S; Gullo-Brown J; Guo P; Kim SH; Lee FY; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Manne V
    J Med Chem; 2000 Oct; 43(20):3587-95. PubMed ID: 11020273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors.
    Angibaud P; Bourdrez X; Devine A; End DW; Freyne E; Ligny Y; Muller P; Mannens G; Pilatte I; Poncelet V; Skrzat S; Smets G; Van Dun J; Van Remoortere P; Venet M; Wouters W
    Bioorg Med Chem Lett; 2003 May; 13(9):1543-7. PubMed ID: 12699751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase.
    Ding CZ; Batorsky R; Bhide R; Chao HJ; Cho Y; Chong S; Gullo-Brown J; Guo P; Kim SH; Lee F; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Yan N; Manne V; Hunt JT
    J Med Chem; 1999 Dec; 42(25):5241-53. PubMed ID: 10602709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-imidazolylalkanamido-1-carboxylalkylbenzo-diazepine, a novel series of farnesyltransferase inhibitors.
    Wan SB; Chu FM; Guo ZR
    Yao Xue Xue Bao; 2002 Jul; 37(7):516-21. PubMed ID: 12914320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridone-containing farnesyltransferase inhibitors: synthesis and biological evaluation.
    Hasvold LA; Wang W; Gwaltney SL; Rockway TW; Nelson LT; Mantei RA; Fakhoury SA; Sullivan GM; Li Q; Lin NH; Wang L; Zhang H; Cohen J; Gu WZ; Marsh K; Bauch J; Rosenberg S; Sham HL
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4001-5. PubMed ID: 14592494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of conformationally constrained 5,6,7, 8-Tetrahydroimidazo[1,5-a]pyridine inhibitors of farnesyltransferase.
    Dinsmore CJ; Zartman CB; Baginsky WF; O'Neill TJ; Koblan KS; Chen IW; McLoughlin DA; Olah TV; Huff JR
    Org Lett; 2000 Nov; 2(22):3473-6. PubMed ID: 11082012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical evaluation of farnesyltransferase inhibitors.
    Baum C; Kirschmeier P
    Curr Oncol Rep; 2003 Mar; 5(2):99-107. PubMed ID: 12583826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.